Intellia Therapeutics Inc
General ticker "NTLA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.4B
Intellia Therapeutics Inc does not follow the US Stock Market performance with the rate: -19.9%.
Estimated limits based on current volatility of 3.4%: low 11.75$, high 12.58$
Factors to consider:
- Current price 32.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [17.96$, 40.69$]
- 2024-12-30 to 2025-12-30 estimated range: [19.20$, 41.08$]
Financial Metrics affecting the NTLA estimates:
- Negative: Non-GAAP EPS, $ of -5.41 <= 0.10
- Negative: Operating profit margin, % of -93.42 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -12.76 <= 2.35
- Positive: -0.96 < Investing cash flow per share, $ of -0.35
Short-term NTLA quotes
Long-term NTLA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $33.05MM | $52.12MM | $36.27MM |
| Operating Expenses | $300.90MM | $510.29MM | $551.57MM |
| Operating Income | $-267.85MM | $-458.16MM | $-515.29MM |
| Non-Operating Income | $-0.04MM | $-16.02MM | $34.10MM |
| Interest Expense | $0.00MM | $8.54MM | $0.00MM |
| R&D Expense | $229.81MM | $419.98MM | $435.07MM |
| Income(Loss) | $-267.89MM | $-474.19MM | $-481.19MM |
| Taxes | $-8.17MM | $16.02MM | $0.00MM |
| Profit(Loss) | $-259.72MM | $-490.21MM | $-481.19MM |
| Stockholders Equity | $1,040.24MM | $1,235.58MM | $1,050.17MM |
| Inventory | $337.36MM | $69.34MM | $0.00MM |
| Assets | $1,294.46MM | $1,520.11MM | $1,300.98MM |
| Operating Cash Flow | $-225.03MM | $-333.29MM | $-394.09MM |
| Capital expenditure | $12.76MM | $58.39MM | $13.98MM |
| Investing Cash Flow | $-550.78MM | $160.31MM | $-31.35MM |
| Financing Cash Flow | $736.69MM | $582.96MM | $130.32MM |
| Earnings Per Share* | $-3.66 | $-6.37 | $-5.42 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.